Identification of novel F508del-CFTR traffic correctors among triazole derivatives-Reference-Cited by-同舟云学术

Identification of novel F508del-CFTR traffic correctors among triazole derivatives

Published:2023-01 Issue: Volume:938 Page:175396
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Bacalhau Mafalda,Ferreira Filipa C.,Kmit Arthur,Souza Felipe R.,da Silva Verônica D.,Pimentel André S.,Amaral Margarida D.,Buarque Camilla D.,Lopes-Pacheco Miquéias^ORCID

Funder

Cystic Fibrosis Foundation

Gilead Sciences

Gilead Research Scholars Program

Fundação para a Ciência e a Tecnologia

Publisher

Elsevier BV

Subject

Pharmacology

Reference67 articles.

1. Pharmacological chaperones improve intra-domain stability and inter-domain assembly via distinct binding sites to rescue misfolded CFTR;Baatallah;Cell. Mol. Life Sci.,2021

2. Failure of cAMP agonists to activate rescued ΔF508 CFTR in CFBE41o- airway epithelial monolayers;Bebok;J. Physiol.,2005

3. The protein data bank;Berman;Nucleic Acids Res.,2000

4. The 1,2,3-triazole ring as a bioisostere in medicinal chemistry;Bonandi;Drug Discov. Today,2017

5. Protein traffic disorders : an effective high-throughput fluorescence microscopy pipeline for drug discovery;Botelho;Sci. Rep.,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct access of 4-acyl-1,2,3-triazoles from acetophenones: A synthetic shortcut for novel p.Phe508del-CFTR traffic correctors;Journal of Molecular Structure;2025-02

2. PTI-801 (posenacaftor) shares a common mechanism with VX-445 (elexacaftor) to rescue p.Phe508del-CFTR;European Journal of Pharmacology;2024-03

3. Organic Synthesis and Current Understanding of the Mechanisms of CFTR Modulator Drugs Ivacaftor, Tezacaftor, and Elexacaftor;Molecules;2024-02-10

4. Small molecule modulators of cystic fibrosis transmembrane conductance regulator (CFTR): Structure, classification, and mechanisms;European Journal of Medicinal Chemistry;2024-02

5. The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?;Expert Opinion on Pharmacotherapy;2023-07-03